CRT 2023
Evening Symposium: Equality, Diversity and Inclusion: Addressing Inequalities in Interventional Cardiology and Healthcare
Wayne Batchelor, MD, MHS
Director, Interventional Cardiology and Interventional Research and Innovation
Inova Heart & Vascular Institute
Falls Church, Virginia, United States
Disclosure(s): Abbott: Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Idorsia Pharmaceuticals: Clinical Trial Support (Ongoing), Consultant (Ongoing); Medtronic Cardiovascular: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); V Wave: Consultant (Ongoing)
Sara D. Collins, MD (she/her/hers)
Attending Physician
Chesapeake Cardiac Care
Bowie, Maryland, United States
No relationships to disclose
Aaron Horne, Jr., MD, MBA
Structural Interventionalist
Summit Health
Berkeley Heights, New Jersey, United States
Disclosure(s): No financial relationships to disclose
Spencer B. King, III, MD, MACC, MSCAI
Professor of Medicine Emeritus
Emory University
Atlanta, Georgia, United States
No relationships to disclose
James C. Blankenship, MD, MHCM, MSCAI, MACC
Director of Cardiology, University of New Mexico
University of New Mexico
Danville, Pennsylvania, United States
No relationships to disclose
Joaquin E. Cigarroa, MD
Head of the Division of Cardiovascular Medicine
OHSU Knight Cardiovascular Institute
Portland, Oregon, United States
No relationships to disclose
Farshad Forouzandeh, MD, PhD (he/him/his)
Associate Professor of Medicine, Interventional Cardiologist
Harrington Heart and Vascular Institute, University Hospitals, Case Western Reserve University, Cleveland, OH
Cleveland, Ohio, United States
No relationships to disclose
David F. Kong, MD, AM, DMT (he/him/his)
Associate Professor of Medicine
Duke University
Durham, North Carolina, United States
Disclosure(s): Medtronic: University Grants/Research Support (Ongoing); Philips: University Grants/Research Support (Ongoing)
Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC
Professor of Medicine
Yale School of Medicine
New Haven, Connecticut, United States
No relationships to disclose
Ryan D. Madder, MD
Section Chief of Interventional Cardiology & Director of Cardiac Cath Lab
Spectrum Health
Ada, Michigan, United States
Disclosure(s): Abbott Vascular: Speakers' Bureau (Ongoing); Corindus: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); InfraRedx: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Spectrawave: Consultant (Ongoing), Scientific Advisory Board (Ongoing)
Eric A. Secemsky, MD, MSc
Director of Vascular Intervention
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Disclosure(s): Abbott, Bayer, BD, Boston Scientific, Cook, CSI, Inari, Medtronic, Philips, Shockwave and VentureMed.: Advisor (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Consulting fees or other remuneration (Ongoing), Grant/Research Support (Ongoing), Other Research Support (Ongoing), Scientific Advisory Board (Ongoing)
Kimberly A. Skelding, MD, FACC, FSCAI (she/her/hers)
Interventional Cardiologist
Confluence Health
Wenatchee, Washington, United States
Disclosure(s): Medtronic Cardiovascular: Consultant/Advisory Board (Ongoing), Proctor (Ongoing)
Craig M. Walker, MD
Chief Medical Director/President/Founder
Cardiovascular Institute of the South
Gray, Louisiana, United States
No relationships to disclose
Kim Allan Williams, Sr., MD, MACC, FAHA, MASNC, FESC
Chair, Department of Medicine
University of Louisville
Louisville, Kentucky, United States
No relationships to disclose